Priscila S. Scheucher

Sao Paulo, SP, Brazil

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 27 publications

Bone marrow and peripheral blood HLA-G in hematologic diseases presenting with impaired erythropoiesis: HLA-G in disorders with impaired erythropoiesis.

Bone marrow and peripheral blood HLA-G in hematologic diseases presenting with impaired erythropoiesis: HLA-G in disorders with impaired erythropoiesis.

Journal: Human immunology

Published: November 02, 2025

Autophagy inhibition potentiates the antileukemic effect of FLT3 inhibitors and overcomes resistance in FLT3-ITD acute myeloid leukemia.

Autophagy inhibition potentiates the antileukemic effect of FLT3 inhibitors and overcomes resistance in FLT3-ITD acute myeloid leukemia.

Journal: Cell death discovery

Published: October 14, 2025

The oncogenic ΔNp73 isoform contributes to aggressiveness in acute promyelocytic leukemia.

The oncogenic ΔNp73 isoform contributes to aggressiveness in acute promyelocytic leukemia.

Journal: Haematologica

Published: September 08, 2025

Differential cytotoxic activity of pharmacological inhibitors of IGF1R-related pathways in JAK2V617F driven cells.

Differential cytotoxic activity of pharmacological inhibitors of IGF1R-related pathways in JAK2V617F driven cells.

Journal: Toxicology in vitro : an international journal published in association with BIBRA

Published: March 16, 2022

Phenformin increases early hematopoietic progenitors in the Jak2V617F murine model.

Phenformin increases early hematopoietic progenitors in the Jak2V617F murine model.

Journal: Investigational new drugs

Published: October 29, 2021

STMN1 is highly expressed and contributes to clonogenicity in acute promyelocytic leukemia cells.

STMN1 is highly expressed and contributes to clonogenicity in acute promyelocytic leukemia cells.

Journal: Investigational new drugs

Published: September 03, 2021

The Combination of Gefitinib With ATRA and ATO Induces Myeloid Differentiation in Acute Promyelocytic Leukemia Resistant Cells.

The Combination of Gefitinib With ATRA and ATO Induces Myeloid Differentiation in Acute Promyelocytic Leukemia Resistant Cells.

Journal: Frontiers in oncology

Published: March 26, 2021

Association between leukocyte telomere length and sex by quantile regression analysis.

Association between leukocyte telomere length and sex by quantile regression analysis.

Journal: Hematology, transfusion and cell therapy

Published: September 21, 2020

NT157, an IGF1R-IRS1/2 inhibitor, exhibits antineoplastic effects in pre-clinical models of chronic myeloid leukemia.

NT157, an IGF1R-IRS1/2 inhibitor, exhibits antineoplastic effects in pre-clinical models of chronic myeloid leukemia.

Journal: Investigational new drugs

Published: August 24, 2020

Eltrombopag preferentially expands haematopoietic multipotent progenitors in human aplastic anaemia.

Eltrombopag preferentially expands haematopoietic multipotent progenitors in human aplastic anaemia.

Journal: British journal of haematology

Published: August 14, 2020

Interleukin-8 is not a predictive biomarker for the development of the acute promyelocytic leukemia differentiation syndrome.

Interleukin-8 is not a predictive biomarker for the development of the acute promyelocytic leukemia differentiation syndrome.

Journal: BMC cancer

Published: June 11, 2020

NTAL is associated with treatment outcome, cell proliferation and differentiation in acute promyelocytic leukemia.

NTAL is associated with treatment outcome, cell proliferation and differentiation in acute promyelocytic leukemia.

Journal: Scientific reports

Published: January 07, 2020

Showing 1-12 of 27

Last Updated: 09/26/2026